Latest Articles

Article Type

Open Access
Appraising Animal Models of Prostate Cancer for Translational Research: Future Directions
ELISABETE NASCIMENTO-GONCALVES, FERNANDA SEIXAS, RUI M. GIL DA COSTA, MARIA JOAO PIRES, MARIA JOAO NEUPARTH, DANIEL MOREIRA-GONCALVES, MARGARIDA FARDILHA, ANA I. FAUSTINO-ROCHA, BRUNO COLACO, RITA FERREIRA and PAULA A. OLIVEIRA

Anticancer Research January 2023, 43 (1) 275-281; DOI: https://doi.org/10.21873/anticanres.16160
You have access
Endoluminal Suture-technique for the Stomach Closure of an Experimental Model
PETER HALVAX, BALAZS NEMETH, ISTVAN KISS, ANDRAS PAPP and ANDRAS VERECZKEI

Anticancer Research January 2023, 43 (1) 59-61; DOI: https://doi.org/10.21873/anticanres.16134
You have access
Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling
YOORHA KANG, MINA HAN, MINSONG KIM, HYUN JU HWANG, BYUNG CHAN AHN, EUNYOUNG TAK, GI-WON SONG, SHIN HWANG, KYUNG-NAM KOH, DONG-HWAN JUNG and NAYOUNG KIM

Anticancer Research January 2023, 43 (1) 63-73; DOI: https://doi.org/10.21873/anticanres.16135
You have access
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience
ONDREJ FIALA, PETR HOSEK, HANA KORUNKOVA, MILAN HORA, JIRI KOLAR, JINDRA WINDRICHOVA, ONDREJ SOREJS, ONDREJ TOPOLCAN, IVAN TRAVNICEK, HANA SEDLACKOVA and JINDRICH FINEK

Anticancer Research January 2023, 43 (1) 463-471; DOI: https://doi.org/10.21873/anticanres.16183
You have access
Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors
NAR BAHADUR KATUWAL, NAHEE PARK, KAMAL PANDEY, MIN SIL KANG, SA DEOK HONG, MITHUN GHOSH, SEUL-GI KIM, YOUNG BIN CHO, JIN HUR, SEUNG KI KIM and YONG WHA MOON

Anticancer Research January 2023, 43 (1) 85-95; DOI: https://doi.org/10.21873/anticanres.16137
You have access
Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage
HAINIAO XIAO, ZHIGANG WU, QINQUAN WANG, CHAOFENG ZHOU, FENG LU and YUNBEI XIAO

Anticancer Research January 2023, 43 (1) 389-403; DOI: https://doi.org/10.21873/anticanres.16174
You have access
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer
MARIA ROSARIA VALERIO, VINCENZO SERRETTA, DEMETRIO ARICO, IVAN FAZIO, VINCENZO ALTIERI, SERGIO BALDARI, MICHELE PENNISI, ANDREA GIRLANDO, MASSIMILIANO SPADA, CRISTINA SCALISI GESOLFO, MARCO MESSINA, CARLO MESSINA, LEONE GIORGIA, GIOVANNI SORTINO, ALFIO DI GRAZIA, ROSSELLA GUGGINO, NICOLO BORSELLINO, DARIO PIAZZA and VITTORIO GEBBIA

Anticancer Research January 2023, 43 (1) 501-508; DOI: https://doi.org/10.21873/anticanres.16187
Open Access
Effect of Antibiotic Treatment on Attenuated Salmonella typhimurium VNP20009 Mediated Schwannoma Growth Control
SHERIF G. AHMED and GARY J. BRENNER

Anticancer Research January 2023, 43 (1) 1-6; DOI: https://doi.org/10.21873/anticanres.16127
You have access
Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia
LI-WEN CHANG, SHIAN-SHIANG WANG, CHENG-KUANG YANG, KEVIN LU, CHUAN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU and JIAN-RI LI

Anticancer Research January 2023, 43 (1) 485-491; DOI: https://doi.org/10.21873/anticanres.16185
Open Access
Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy
MARK A. SUCKOW and MICHAEL C. HILES

Anticancer Research January 2023, 43 (1) 335-341; DOI: https://doi.org/10.21873/anticanres.16168

Main menu

User menu

Search

Latest Articles

Pages